7 results match your criteria: "Institute for Emerging Diseases and Innovative Therapies[Affiliation]"
PLoS One
June 2016
Vaccine Research Institute, Créteil, France; INSERM UMR 955, Equipe 16, Créteil, France; Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, service d'immunologie clinique, Créteil, France; Université Paris Est, Faculté de médecine, Créteil, France.
Targeting dendritic cell-specific endocytic receptors using monoclonal antibodies fused to desired antigens is an approach widely used in vaccine development to enhance the poor immunogenicity of protein-based vaccines and to induce immune responses. Here, we engineered an anti-human DCIR recombinant antibody, which cross-reacts with the homologous cynomolgous macaque receptor and was fused via the heavy chain C-terminus to HIV Gagp24 protein (αDCIR.Gagp24).
View Article and Find Full Text PDFJ Immunol Methods
November 2015
CEA, Division of Immuno-Virology, Institute for Emerging Diseases and Innovative Therapies (iMETI), 92265 Fontenay-aux-Roses, France; UMR 1184, Université Paris-Sud, 91405 Orsay, France; Inserm U1184, 92265 Fontenay-aux-Roses, France; Vaccine Research Institute (VRI), 94010 Créteil, France. Electronic address:
The skin is a valuable target for vaccine delivery because it contains many immune cell populations, notably antigen presenting cells. Skin immune cells have been extensively described in mice and humans but not in non-human primates, which are pertinent models for immunological research in vaccination. The aim of this work was to describe immune cell populations in the epidermis, dermis and skin draining lymph nodes in cynomolgus macaques by a single 12-parameter flow cytometry protocol.
View Article and Find Full Text PDFCytometry A
April 2015
CEA, Division of Immuno-Virology, IDMIT Center, Institute for Emerging Diseases and Innovative Therapies (iMETI), DSV, Fontenay-aux-Roses, France; Université Paris-Sud, UMR E1, Orsay, France; Vaccine Research Institute (VRI), Créteil, France.
The recent introduction of mass cytometry, a technique coupling a cell introduction system generating a stream of single cells with mass spectrometry, has greatly increased the number of parameters that can be measured per single cell. As with all new technology there is a need for dissemination of standardization and quality control procedures. Here, we characterize variations in sensitivity observed across the mass range of a mass cytometer, using different lanthanide tags.
View Article and Find Full Text PDFJ Immunol
September 2014
French Alternative Energies and Atomic Energy Commission, Division of Immuno-Virology, Institute for Emerging Diseases and Innovative Therapies, Infectious Diseases Models for Innovative Therapies Center, 92265 Fontenay-aux-Roses, France; Unité Mixte de Recherche E1, Université Paris-Sud, 91405 Orsay, France; Vaccine Research Institute, 94010 Créteil, France; INSERM, 75014 Paris, France
Dendritic cells are major APCs that can efficiently prime immune responses. However, the roles of skin-resident Langerhans cells (LCs) in eliciting immune responses have not been fully understood. In this study, we demonstrate for the first time, to our knowledge, that LCs in cynomolgus macaque skin are capable of inducing antiviral-specific immune responses in vivo.
View Article and Find Full Text PDFMethods Mol Biol
September 2014
Division of Immuno-Virology, CEA, Institute for Emerging Diseases and Innovative Therapies (iMETI), Fontenay-aux-Roses, France.
Strategies to improve vaccine efficacy are still required. The immunogenicity of DNA vaccines is strongly improved by electroporation (EP). The skin is populated with a wide variety of immune cells, making it an attractive tissue for vaccine delivery.
View Article and Find Full Text PDFEur J Immunol
August 2012
CEA, Division of Immuno-Virology, Institute for Emerging Diseases and Innovative Therapies, DSV, Fontenay-aux-Roses, France.
The pivotal role of DCs in initiating immune responses led to their use as vaccine vectors. However, the relationship between DC subsets involved in antigen presentation and the type of elicited immune responses underlined the need for the characterization of the DCs generated in vitro. The phenotypes of tissue-derived APCs from a cynomolgus macaque model for human vaccine development were compared with ex vivo-derived DCs.
View Article and Find Full Text PDFHum Gene Ther
November 2009
Division of Immunovirology, Life Sciences Program (DSV), Institute for Emerging Diseases and Innovative Therapies, Atomic Energy Commission (CEA), Fontenay aux Roses, France.
Strategies to improve vaccine efficacy are still required, especially in the case of chronic infections, including human immunodeficiency virus (HIV). DNA vaccines have potential advantages over conventional vaccines; however, low immunological efficacy has been demonstrated in many experiments involving large animals and in clinical trials. To improve the immunogenicity of DNA vaccines, we have designed a plasmid vector exploiting the binding capacity of the bovine papillomavirus E2 protein and we have used electroporation (EP) to increase DNA uptake after intradermal inoculation.
View Article and Find Full Text PDF